QuickView for HLA-A specific activating MHC class I receptor activity (biogroup)

1. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
2. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
3. Drug Matrix In Vivo Toxicogenomic Study - Rat Thigh [Codelink]
4. Drug Matrix In Vivo Toxicogenomic Study - Rat Bone Marrow [Codelink]
5. Drug Matrix In Vitro Toxicogenomic Study - Rat Hepatocytes [Codelink]

There were no matches for HLA-A specific activating MHC class I receptor activity

1. T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1…
2. Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persiste…
3. Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Base…
4. Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
5. Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults